American Society of Clinical Oncology

Latest stories

11h
Japan Today
New guidelines for cancer doctors aim to make sense of gene tests ‹ Japan TodayThe American Society of Clinical Oncology (ASCO) has issued guidelines on how c
New guidelines for cancer doctors aim to make sense of gene tests ‹ Japan Today
Japan Today / Posted 11 hours ago
The American Society of Clinical Oncology (ASCO) has issued guidelines on how cancer doctors should approach the use of new genetic tests that screen for multiple cancer genes at the same time, including counseling patients about genes whose... Read more
2d
MedCity News
Bristol-Myers Squibb will acquire immunotherapy group PromediorPRINCETON, NEW JERSEY, UNITED STATES – 2014/08/10: Bristol-Myers Squibb R&D hea
Bristol-Myers Squibb will acquire immunotherapy group Promedior
MedCity News / Posted 2 days ago
PRINCETON, NEW JERSEY, UNITED STATES – 2014/08/10: Bristol-Myers Squibb R&D headquarters. (Photo by John Greim/LightRocket via Getty Images) Bristol-Myers Squibb has paid for the right to acquire US clinical stage immunotherapy group Promedior in a... Read more
3d
Channel NewsAsia
New guidelines for cancer doctors aim to make sense of gene testsCHICAGO: The American Society of Clinical Oncology (ASCO) has issued guidelines
New guidelines for cancer doctors aim to make sense of gene tests
Channel NewsAsia / Posted 3 days ago
CHICAGO: The American Society of Clinical Oncology (ASCO) has issued guidelines on how cancer doctors should approach the use of new genetic tests that screen for multiple cancer genes at the same time, including counseling patients about genes whose... Read more
8d
ScienceBlogs
Acupuncture bait and switch: Hot flash editionIt’s always disappointing to see a good journal fall for bad medicine, particul
Acupuncture bait and switch: Hot flash edition
ScienceBlogs / Posted 8 days ago
It’s always disappointing to see a good journal fall for bad medicine, particularly when it’s in your field. For example, the Journal of Clinical Oncology (affectionately referred to by its abbreviation JCO) is the official journal of the American... Read more
2 related stories
9d
Japan Today
New tool will compare costs versus benefits of cancer treatments ‹ Japan TodayAs options for cancer patients become increasingly complicated, and expensive,
New tool will compare costs versus benefits of cancer treatments ‹ Japan Today
Japan Today / Posted 9 days ago
As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available therapies. The... Read more
2 related stories
10d
News-Medical-Net
Dr. Sharma receives research award from ASCO to continue study on triple-negative breast cancerDr. Sharma was awarded the 2015 Advanced Clinical Research Award in Breast Canc
Dr. Sharma receives research award from ASCO to continue study on triple-negative breast cancer
News-Medical-Net / Posted 10 days ago
Dr. Sharma was awarded the 2015 Advanced Clinical Research Award in Breast Cancer from the American Society of Clinical Oncology to continue her research on triple-negative breast cancer detailed below. How do you treat a cancer that does not have a... Read more
10d
Philly.com
New tool will compare costs versus benefits of cancer treatmentsOther medical groups are also trying to address the cost issue, but not as dire
New tool will compare costs versus benefits of cancer treatments
Philly.com / Posted 10 days ago
Other medical groups are also trying to address the cost issue, but not as directly as the NCCN. The American Society of Clinical Oncology (ASCO) is developing its own tool for valuing treatments, but says that its "net health benefit" scores will... Read more
2 related stories
10d
The Advocate
A 'major milestone' for Baton Rouge firm’s cancer treatment: It helps shrink tumors during clinical trialsBaton Rouge-based Esperance Pharmaceuticals Inc. said one of its new developmen
A 'major milestone' for Baton Rouge firm’s cancer treatment: It helps shrink tumors during clinical trials
The Advocate / Posted 10 days ago
Baton Rouge-based Esperance Pharmaceuticals Inc. said one of its new developmental drugs helped shrink tumors among ovarian cancer patients during a Phase II clinical trial. The latest test of EP-100 involved 50 patients and was designed to evaluate... Read more
3 related stories
10d
WJHG Panama City
Cancer in Older AdultsCLEVELAND CLINIC-- Former President Jimmy Carter recently announced that he has
Cancer in Older Adults
WJHG Panama City / Posted 10 days ago
CLEVELAND CLINIC-- Former President Jimmy Carter recently announced that he has cancer. Carter is 90 years old and says the cancer has spread. Dr. Dale Shepard is a cancer expert at Cleveland Clinic. He said generally older adults have a higher risk... Read more
10d
FOX News
New tool will compare costs and benefits of cancer treatmentsLOS ANGELES – As options for cancer patients become increasingly complicated, a
New tool will compare costs and benefits of cancer treatments
FOX News / Posted 10 days ago
LOS ANGELES – As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available... Read more
2 related stories
13d
Zawya
New tool will compare costs and benefits of cancer treatmentsHealthcareLOS ANGELES, Aug 21 (Reuters) - As options for cancer patients become increasin
New tool will compare costs and benefits of cancer treatmentsHealthcare
Zawya / Posted 13 days ago
LOS ANGELES, Aug 21 (Reuters) - As options for cancer patients become increasingly complicated, and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits... Read more
13d
Business Insurance
New tool will compare costs and benefits of cancer treatments(Reuters) — As options for cancer patients become increasingly complicated and
New tool will compare costs and benefits of cancer treatments
Business Insurance / Posted 13 days ago
(Reuters) — As options for cancer patients become increasingly complicated and expensive, the most influential source for U.S. oncology treatment guidelines will for the first time offer a tool to assess the costs versus benefits of available... Read more
13d
FOX 59 Indianapolis
No ordinary patient: Carter's Stage IV melanoma and how it will be treatedATLANTA, Ga. (Aug. 21, 2015) — Hearing a diagnosis of advanced melanoma, former
No ordinary patient: Carter's Stage IV melanoma and how it will be treated
FOX 59 Indianapolis / Posted 13 days ago
ATLANTA, Ga. (Aug. 21, 2015) — Hearing a diagnosis of advanced melanoma, former President Jimmy Carter said he thought he had a few weeks to live, but was “surprisingly at ease” and that he trusted in the treatment prescribed by his doctors at Emory... Read more
1159 related stories
14d
FOX 11 Reno
No ordinary patient: Carter's Stage IV melanoma and how it will be treatedATLANTA (CNN) -- Hearing a diagnosis of advanced melanoma, former President Jim
No ordinary patient: Carter's Stage IV melanoma and how it will be treated
FOX 11 Reno / Posted 14 days ago
ATLANTA (CNN) -- Hearing a diagnosis of advanced melanoma, former President Jimmy Carter said he thought he had a few weeks to live, but was "surprisingly at ease" and that he trusted in the treatment prescribed by his doctors at Emory... Read more
1159 related stories
14d
News 4 Reno
No ordinary patient: Carter's Stage IV melanoma and how it will be treatedATLANTA (CNN) -- Hearing a diagnosis of advanced melanoma, former President Jim
No ordinary patient: Carter's Stage IV melanoma and how it will be treated
News 4 Reno / Posted 14 days ago
ATLANTA (CNN) -- Hearing a diagnosis of advanced melanoma, former President Jimmy Carter said he thought he had a few weeks to live, but was "surprisingly at ease" and that he trusted in the treatment prescribed by his doctors at Emory... Read more
1159 related stories
14d
FOX 8 WGHP
No ordinary patient: Carter's Stage IV melanoma and how it will be treatedFormer President Jimmy Carter (CNN) ATLANTA — Hearing a diagnosis of advanced
No ordinary patient: Carter's Stage IV melanoma and how it will be treated
FOX 8 WGHP / Posted 14 days ago
Former President Jimmy Carter (CNN) ATLANTA — Hearing a diagnosis of advanced melanoma, former President Jimmy Carter said he thought he had a few weeks to live but was “surprisingly at ease” and that he trusted in the treatment prescribed by his... Read more
1159 related stories
14d
CNN
Jimmy Carter's melanoma treatmentAtlanta (CNN)Hearing a diagnosis of advanced melanoma, former President Jimmy C
Jimmy Carter's melanoma treatment
CNN / Posted 14 days ago
Atlanta (CNN)Hearing a diagnosis of advanced melanoma, former President Jimmy Carter said he thought he had a few weeks to live, but was "surprisingly at ease" and that he trusted in the treatment prescribed by his doctors at Emory University. The... Read more
1159 related stories
15d
Channel NewsAsia
Jurong GRC: Rahayu Mahzam, Tan Wu Meng join PAP slateSINGAPORE: The People’s Action Party (PAP) on Thursday (Aug 20) officially intr
Jurong GRC: Rahayu Mahzam, Tan Wu Meng join PAP slate
Channel NewsAsia / Posted 15 days ago
SINGAPORE: The People’s Action Party (PAP) on Thursday (Aug 20) officially introduced its new candidates for the Jurong Group Representation Constituency (GRC) for the coming General Election (GE). The incumbent party’s five-person team features two... Read more
21d
Business Wire
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Second Quarter Ended June 30, 2015HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a clin
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Second Quarter Ended June 30, 2015
Business Wire / Posted 21 days ago
HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today reported financial results for the second quarter of 2015,... Read more
21d
Business Wire
Sirtex Medical Inc. Announces 21.2 Percent Dose Sales Growth of SIR-Spheres® Y-90 resin microspheres in Fourth QuarterWOBURN, Mass.--(BUSINESS WIRE)--Sirtex Medical Inc., a subsidiary of Sirtex Med
Sirtex Medical Inc. Announces 21.2 Percent Dose Sales Growth of SIR-Spheres® Y-90 resin microspheres in Fourth Quarter
Business Wire / Posted 21 days ago
WOBURN, Mass.--(BUSINESS WIRE)--Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited (ASX:SRX), a leading manufacturer of targeted, liver cancer therapies, today announced dose sales of SIR-Spheres® Y-90 resin microspheres grew 21.2 percent,... Read more
24d
Business Wire
BioTime, Inc. Reports Second Quarter 2015 Results and Recent DevelopmentsALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today reported f
BioTime, Inc. Reports Second Quarter 2015 Results and Recent Developments
Business Wire / Posted 24 days ago
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT:BTX) today reported financial results for the second quarter ended June 30, 2015 and provided a corporate update. “BioTime’s management team has sharpened its focus on our high priority... Read more
25d
Arkansas Democrat-Gazette
Cold nips hair loss in chemotherapyWhen Kim Nyalka decided on chemotherapy for her breast cancer, first she looked
Cold nips hair loss in chemotherapy
Arkansas Democrat-Gazette / Posted 25 days ago
When Kim Nyalka decided on chemotherapy for her breast cancer, first she looked into wigs. Then she thought of her 7-year-old daughter's fingers stroking her hair and remembered long-ago baby fingers twirling it. And Nyalka decided to try scalp... Read more
26d
Philly.com
For cancer survivors, adoption can be next ordealAs she talked, she cuddled the life-transforming result of that choice, their d
For cancer survivors, adoption can be next ordeal
Philly.com / Posted 26 days ago
As she talked, she cuddled the life-transforming result of that choice, their daughter, Adele. When the pigtailed 15-month-old got too squirmy, Sean, 32, took over, providing a pacifier, a toy, and a lap where she fell into the profound sleep of a... Read more
27d
CBS Sports
Olympic champion Davis vows he'll 'continue to fight'Boxing fans of a certain age still remember the 1976 U.S. Olympic team. Those
Olympic champion Davis vows he'll 'continue to fight'
CBS Sports / Posted 27 days ago
Boxing fans of a certain age still remember the 1976 U.S. Olympic team. Those Americans took Montreal by storm over two weeks in late July, winning seven medals in 11 weight classes -- besting Cubans and Russians along the way -- including golds... Read more
28d
News-Medical-Net
Clinical study shows two-drug combination can prolong survival in men with metastatic prostate cancerNewly diagnosed patients with metastatic, hormone-sensitive prostate cancer gai
Clinical study shows two-drug combination can prolong survival in men with metastatic prostate cancer
News-Medical-Net / Posted 28 days ago
Newly diagnosed patients with metastatic, hormone-sensitive prostate cancer gained a dramatic survival benefit when started on two drugs simultaneously, rather than delaying the second drug until the cancer began to worsen, according to results of a... Read more
29d
Newswise
New Approach to Decades Old Treatment Yields Increased Survival for Some Prostate Cancer Patients Newswise — New Brunswick, N.J., August 5, 2015 – For more than 60 years, the
New Approach to Decades Old Treatment Yields Increased Survival for Some Prostate Cancer Patients
Newswise / Posted 29 days ago
Newswise — New Brunswick, N.J., August 5, 2015 – For more than 60 years, the standard of care for patients with prostate cancer fueled by androgen... Read more
1m
The Irish Times
New ‘cocktails’ will test limits of cancer drug pricing Immunotherapy combinations to push prices to new highs as worldwide cancer dru
New ‘cocktails’ will test limits of cancer drug pricing
The Irish Times / Posted a month ago
Immunotherapy combinations to push prices to new highs as worldwide cancer drug spending hits $100bn in 2014 New cancer drug cocktails set to reach the market in the next few years will test... Read more
4 related stories
1m
Reuters UK Edition
New cocktails to test limits of cancer drug pricingLONDON New cancer drug cocktails set to reach the market in the next few years
New cocktails to test limits of cancer drug pricing
Reuters UK Edition / Posted a month ago
LONDON New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. The growing reluctance of governments... Read more
4 related stories
1m
News-Medical-Net
Array Biopharma reports strong fourth quarter and full year 2015 financial resultsArray BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quart
Array Biopharma reports strong fourth quarter and full year 2015 financial results
News-Medical-Net / Posted a month ago
Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015. Ron Squarer, Chief Executive Officer of Array, noted, "Binimetinib and encorafenib, two innovative oncology... Read more
m
iol.co.za
The high cost of immunotherapyREUTERSDozens of new cancer combinations will be launched over the next few yea
The high cost of immunotherapy
iol.co.za / Posted 1 months ago
REUTERSDozens of new cancer combinations will be launched over the next few years, with ones for lung cancer, melanoma and other solid tumours taking off strongly after 2018, drug company pipelines suggest. London - New cancer drug cocktails set to... Read more
4 related stories
m
Channel NewsAsia
New cocktails to test limits of cancer drug pricingLONDON: New cancer drug cocktails set to reach the market in the next few years
New cocktails to test limits of cancer drug pricing
Channel NewsAsia / Posted 1 months ago
LONDON: New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. The growing reluctance of governments... Read more
4 related stories
m
Pilipino Star
Most women don’t know their own breast cancer riskMost women do not have an accurate understanding of their breast cancer risk —
Most women don’t know their own breast cancer risk
Pilipino Star / Posted 1 months ago
Most women do not have an accurate understanding of their breast cancer risk — a finding that has important implications for prevention and early detection, as well as psychological well-being, according to a survey of nearly 10,000 women undergoing... Read more
m
Business Wire
Gilead Sciences maakt financiële resultaten tweede kwartaal 2015 bekendFOSTER CITY, Californië--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD)
Gilead Sciences maakt financiële resultaten tweede kwartaal 2015 bekend
Business Wire / Posted 1 months ago
FOSTER CITY, Californië--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) heeft vandaag haar bedrijfsresultaten bekendgemaakt voor het kwartaal dat eindigde op 30 juni 2015. De volgende financiële resultaten zijn een jaar-op-jaar vergelijking... Read more
4 related stories
m
Business Wire
Gilead Sciences gibt Finanzergebnisse für zweites Quartal 2015 bekanntFOSTER CITY, Kalifornien--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc
Gilead Sciences gibt Finanzergebnisse für zweites Quartal 2015 bekannt
Business Wire / Posted 1 months ago
FOSTER CITY, Kalifornien--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (NASDAQ: GILD), hat heute seine Betriebsergebnisse für das am 30. Juni 2015 beendete Quartal bekannt gegeben. Die folgenden Finanzergebnisse sind ein Vorjahresvergleich... Read more
810 related stories
m
Business Wire
Onxeo Reports First Half 2015 Business Update and Consolidated AccountsOnxeoS.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen:
Onxeo Reports First Half 2015 Business Update and Consolidated Accounts
Business Wire / Posted 1 months ago
OnxeoS.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today reported its consolidated half-year accounts as of June 30, 2015 and provided... Read more
m
Business Wire
Onxeo informerer om sine forretningsmæssige tiltag og resultatet for 1. halvår 2015OnxeoS.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ København -
Onxeo informerer om sine forretningsmæssige tiltag og resultatet for 1. halvår 2015
Business Wire / Posted 1 months ago
OnxeoS.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ København - ONXEO), et innovativt selskab med speciale i udvikling af lægemidler til behandling af sjældne kræftsygdomme, har i dag offentliggjort sit koncernregnskab for 1. halvår... Read more
55 related stories
m
Business Wire
Onxeo SA: Principales avancées et comptes consolidés du premier semestre 2015OnxeoSA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, Nasdaq Copenhague - O
Onxeo SA: Principales avancées et comptes consolidés du premier semestre 2015
Business Wire / Posted 1 months ago
OnxeoSA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, Nasdaq Copenhague - ONXEO), société innovante spécialisée dans le développement de médicaments orphelins en oncologie, publie aujourd’hui ses comptes semestriels consolidés au 30 juin 2015 et... Read more
23 related stories

People in this news